Nature Communications (Sep 2022)
Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy
Abstract
Retinoblastoma response to treatment is difficult to predict. Here, the authors show that DNA methylation of cfDNA from aqueous humour is altered in retinoblastoma patients and can be used to identify the molecular subtypes and potentially predict treatment response.